Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
NCT Number: NCT01710722
The purpose of this study is to compare three treatments to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Baton Rouge, Louisiana, 70808, United States
Three treatments are compared to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Caffeine 200 mg tablets and ephedrine HCl 25 mg tablets three times a day with placebo leptin A-200 subcutaneously once daily.
Leptin A-200 20 mg subcutaneously once daily and placebo tablets of caffeine and ephedrine three times a day.
Caffeine 200 mg tablets and ephedrine HCl tablets 25 mg three times a day with leptin A-200 20 mg subcutaneously once daily.
Time frame: 28 weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Time frame: 28 Weeks
Pennington Biomedical Research Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details